SCHEMBL19507340

SCHEMBL19507340

CCc1cc(F)cc(CC)c1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.50
GABRB2 P47870 1/20 0.50
GRIN2D O15399 3/20 0.33
GRIN3B O60391 3/20 0.33
GRIN1 Q05586 3/20 0.33
GRIN2A Q12879 3/20 0.33
GRIN2B Q13224 3/20 0.33
GRIN2C Q14957 3/20 0.33
GRIN3A Q8TCU5 3/20 0.33
RIPK1 Q13546 3/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28848025 0.81 ERN1 (0.41) GABRA1GABRB2GRIN2DGRIN3BGRIN1
SCHEMBL20681233 0.80 HMGCR (0.41) GABRA1GABRB2LMNAMAPTHTT
SCHEMBL30791023 0.78 HMGCR (0.39) GABRA1GABRB2LMNAMAPT
Ammonia Solution, Strong SCHEMBL29178990 0.78 HMGCR (0.39) GABRA1GABRB2LMNAMAPT
SCHEMBL10717222 0.78 GABRA1 (0.34) GABRA1GABRB2RIPK1
SCHEMBL30014250 0.78 GABRA1 (0.34) GABRA1GABRB2RIPK1
SCHEMBL17873619 0.78 GABRA1 (0.55) GABRA1GABRB2GRIN2DGRIN3BGRIN1
SCHEMBL26200345 0.77 AGTR1 (0.33) GABRA1GABRB2
SCHEMBL469841 0.76 GABRA1 (0.52) GABRA1GABRB2GRIN2DGRIN3BGRIN1
SCHEMBL456782 0.76 GABRA1 (0.52) GABRA1GABRB2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017184604-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY IFM THERAPEUTICS, INC (US) 2017-10-26 WO disclosed